<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A backcross model of New Zealand <z:mp ids='MP_0001261'>obese</z:mp> mice (NZO) with the lean, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>-resistant SJL strain was established to locate genes responsible for <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-like <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In male NZO x F1 backcross mice, a major susceptibility locus for the development of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:mp ids='MP_0002727'>hypoinsulinemia</z:mp> (Nidd/SJL) was identified on chromosome 4 between the markers D4Mit278 and D4Mit232, 10-28 cM distal of the previously described Nidd1 locus </plain></SENT>
<SENT sid="2" pm="."><plain>The diabetogenic allele has presumably been contributed by the SJL genome, and it appeared to be responsible for approximately 60% of the total prevalence of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of Nidd/SJL did not alter body weight or <z:mp ids='MP_0005456'>weight gain</z:mp> by week 12 </plain></SENT>
<SENT sid="4" pm="."><plain>Thereafter, it was associated with <z:mp ids='MP_0001262'>reduced weight</z:mp> gain or <z:hpo ids='HP_0001824'>weight loss</z:hpo>, presumably as a consequence of decompensated <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> male backcross mice, the prevalence of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> at week 22 increased with the body weight at week 12, suggesting that the development of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> was dependent on the degree of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In the absence of Nidd/SJL, mice weighing &lt;50 g at week 12 did not develop <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> by week 22 </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, in animals carrying the diabetogenic allele, the prevalence of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> was 20 and 64% when the 12-week weight was &lt;45 and 45-50 g, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>These data are consistent with the conclusion that Nidd/SJL represents a <z:mp ids='MP_0002055'>diabetes</z:mp> gene that lowers the <z:hpo ids='HP_0001513'>obesity</z:hpo> threshold for the development of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:mp ids='MP_0002727'>hypoinsulinemia</z:mp> </plain></SENT>
</text></document>